Healthcare Resource Consumption for Intermittent Urinary Catheterisation: Cost-effectiveness of Hydrophilic Catheters and Budget Impact Analyses
Overview
Authors
Affiliations
Objectives: This study presents a cost-effectiveness analysis comparing hydrophilic coated to uncoated catheters for patients performing urinary intermittent catheterisation. A national budget impact analysis is also included to evaluate the impact of intermittent catheterisation for management of bladder dysfunctions over a period of 5 years.
Design: A Markov model (lifetime horizon, 1 year cycle length) was developed to project health outcomes (life years and quality-adjusted life years) and economic consequences related to patients using hydrophilic coated or uncoated catheters. The model was populated with catheter-related clinical efficacy data retrieved from randomised controlled trials and quality-of-life data (utility weights) from the literature. Cost data (EUR, 2015) were estimated on the basis of healthcare resource consumption derived from an e-survey addressed to key opinion leaders in the field.
Setting: Italian Healthcare Service perspective.
Population: Patients with spinal cord injury performing intermittent urinary catheterisation in the home setting.
Main Outcome Measures: Incremental cost-effectiveness and cost-utility ratios (ICER and ICUR) of hydrophilic coated versus uncoated catheters and associated healthcare budget impact.
Results: The base-case ICER and ICUR associated with hydrophilic coated catheters were €20 761 and €24 405, respectively. This implies that hydrophilic coated catheters are likely to be cost-effective in comparison to uncoated ones, as proposed Italian threshold values range between €25 000 and €66 400. Considering a market share at year 5 of 89% hydrophilic catheters and 11% uncoated catheters, the additional cost for Italy is approximately €12 million in the next 5 years (current market share scenario for year 0: 80% hydrophilic catheters and 20% uncoated catheters).
Conclusions: Considered over a lifetime, hydrophilic coated catheters are potentially a cost-effective choice in comparison to uncoated ones. These findings can assist policymakers in evaluating intermittent catheterisation in patients with spinal cord injury.
Feasibility study on a new enhanced device for patients with intermittent catheterization (LUJA).
Calabro G, DAmbrosio F, Orsini F, Pappalardo C, Scardigno A, Rumi F J Prev Med Hyg. 2023; 64(3 Suppl 1):E1-E89.
PMID: 38125911 PMC: 10730013. DOI: 10.15167/2421-4248/jpmh2023.64.3s1.
Barken K, Vaabengaard R BMC Urol. 2022; 22(1):153.
PMID: 36123663 PMC: 9487088. DOI: 10.1186/s12894-022-01102-8.
Xi M, Elterman D, Welk B, Pakosh M, Chan B BJUI Compass. 2022; 2(2):71-81.
PMID: 35474888 PMC: 8988762. DOI: 10.1002/bco2.63.
Chughtai B, Rojanasarot S, Neeser K, Gultyaev D, Fu S, Bhattacharyya S PLoS One. 2022; 17(4):e0266824.
PMID: 35427376 PMC: 9012364. DOI: 10.1371/journal.pone.0266824.
Intermittent catheter techniques, strategies and designs for managing long-term bladder conditions.
Prieto J, Murphy C, Stewart F, Fader M Cochrane Database Syst Rev. 2021; 10:CD006008.
PMID: 34699062 PMC: 8547544. DOI: 10.1002/14651858.CD006008.pub5.